首页> 外文期刊>QJM: Monthly journal of the Association of Physicians >Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline
【24h】

Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline

机译:Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline

获取原文
获取原文并翻译 | 示例
       

摘要

A 27-year-old Chinese male presented with a 2-year history of headache and a right temporal field defect. A magnetic resonance imaging (MRI) scan revealed a 5cm tumour in the sphenoid with bilateral cavernous sinus extension and posterior-extension to the clivus (Figured A). This was reported as an erosive skull base tumour and he was referred to neurosurgery. His serum prolactin was measured at 283 909 mU/l (normal range 45-375 mU/l), confirming a giant prolactinoma. After a single dose of 250 meg cabergoline, there was an improvement in his visual field, tumour reduction ajid fall in prolactin to 57 539 mU/l (Figure 1 B). An increased dose of 250 meg twice weekly resulted in further tumour shrinkage, a fall in prolactin and normalization of his visual fields (Figure 1C and D). This case highlights the importance of measurement of serum prolactin in the evaluation of potential skull base tumours and the rapid shrinkage of giant prolactino-mas with primary medical therapy obviating the need for surgery.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号